| Bioactivity | Vemtoberant is an β3 Adrenergic Receptor antagonist. Vemtoberant can be used for research of β3 adrenergic receptor-mediated disorder, such as, heart failure[1][2]. |
| Name | Vemtoberant |
| CAS | 2169905-68-2 |
| Formula | C29H37N3O8S2 |
| Molar Mass | 619.75 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. WHO Drug Information-World Health Organization (WHO). [2]. Tran Thuy-Anh, et al. Preparation of modulators of the beta-3 adrenergic receptor useful for the treatment or prevention of disorders related thereto: World Intellectual Property Organization, WO2017214002. 2017-12-14. |